Tenders Are Invited For Pharmaceutical Products - Conclusion Of A Non-Exclusive Discount Agreement In Accord ...

Work Detail

Pharmaceutical Products - Conclusion Of A Non-Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Meropenem, Atc J01dh02 For The Period March 1St, 2024 - February 28Th, 2026. Dak-Gesundheit Assumes That This Procedure Is Due To A Missing Selection Decision And Therefore The Non-Discriminatory Access For Everyone Pharmaceutical Companies Do Not Fall Within The Scope Of Antitrust Procurement Law Falls. Regardless, It Ends Automatically When The Exclusive Contract Comes Into Force On Meropenem, Atc J01dh02, As A Result Of A Formal Procurement Procedure In Accordance With The Regulations Of Part 4 Of The Gwb With One Or More Contractual Partners. To Ensure The Diversity Of Potential Contractual Partners Within The Framework Of The Approval Model Every Pharmaceutical Company To Conclude A Contract During The Term Of The Contract Framework Agreement At Any Time And Under The Same Conditions. The Ones For This The Necessary Contract Documents Are Available Via The Online Portal Www.Dtvp.De/Center Under 5.1.11. The Link Mentioned Is Available For Download. Requirements For The Conclusion Or Later Accession To The First Came Into Force On March 1, 2024 The Following Documents Must Be Sent In Full And In A Timely Manner (Available For Download At The Link Mentioned Under 5.1.11) To The Following Department At Dak-Gesundheit: 1. Letter Of Offer 2. Recognition Of The Contractual Requirements Of Dak-Gesundheit, In Particular The Specified Discounts Through Submission Of The Contract Bearing The Name Or Company Stamp By The Interested Party Designated Location. 3. The Completed Appendixes 1 And 2 To The Contract. The Prospective Must Enter The Medicinal Products For The Above-Mentioned Active Ingredient Here, Which Are The Subject Of The Contract Should Be. The Documents Must Be Submitted By Email To: Openhouse@Dak.De Dak-Gesundheit Department Of Medicines (0038 00) Nagelsweg 27-31 20097 Hamburg Die Appendix 2 Must Be Sent As An Excel File To The Email Address Openhouse@Dak.De. Contracts Under This Model And For The Above-Mentioned Active Ingredient Are Being Concluded For The First Time Completed With Effect From March 1St, 2024 And End On February 28Th, 2026. Interested Parties Who If You Want To Become A Contractual Partner On This Date, You Have To Submit The Above-Mentioned Documents Submit By Email By The 5Th Of The Previous Month. The Offer Is In Text Form Submit Electronic Offer By E-Mail To Openhouse@Dak.De. Submitting The Offer By Post Is Not Part Of This Procedure Intended. Please Do Not Submit The Offer Via The German Procurement Portal. In Order To Meet The Deadline, All Documents Must Be Received Electronically Via Per Email To The Email Address Openhouse@Dak.De Is Sufficient. Later Memberships Are Possible At Any Time. In Order To Do So During The Term Of The In Order To Be Able To Join The Contract On The 1St Or 15Th Of The Following Month, The Above-Mentioned Documents Must Be Submitted. Regardless Of The Desired Membership, Dak-Gesundheit Must Be Submitted By The 5Th Of The Previous Month. Here Too, It Is Important That Dak-G Receives It In A Timely Manner Via Email. Example: The Bidders Desired Accession Should Take Place On July 15Th. (Following Month), The Documents You Would Have To Do This By June 5Th. (Previous Month). Note: The Publication Takes Place Here Using The Form For Open Procedures. As Already Clear Made, This Is Not The Case - The Announcement Had To Be Made For Technical Reasons, As There Is No Suitable One For The Approval Process Form Exists.

Contact Information

Other Detail